Free Trial

Tourmaline Bio (TRML) SEC Filings & 10K Form

Tourmaline Bio logo
$12.21 -0.16 (-1.29%)
Closing price 04:00 PM Eastern
Extended Trading
$12.42 +0.21 (+1.72%)
As of 05:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Tourmaline Bio SEC Filings

DateFilerForm TypeView
01/29/2025
3:22 PM
Johnson Kevin Bruce (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
3:23 PM
Jones Susan Dana (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
3:23 PM
MIDDLEKAUFF W BRADFORD (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
3:23 PM
Robinson Ryan F. (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
7:44 AM
Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
11:15 PM
Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
Form EFFECT
11/14/2024
4:46 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Tourmaline Bio, Inc. (Subject)
Tourmaline Bio (Subject)
Form SC 13G/A
11/14/2024
3:32 PM
Tourmaline Bio, Inc. (Subject)
Tourmaline Bio (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SC 13G/A
11/14/2024
8:45 AM
Deep Track Capital, LP (Filed by)
Tourmaline Bio, Inc. (Subject)
Tourmaline Bio (Subject)
Form SC 13G/A
11/14/2024
8:39 AM
Avoro Capital Advisors LLC (Filed by)
Tourmaline Bio, Inc. (Subject)
Tourmaline Bio (Subject)
Form SC 13G
11/07/2024
4:21 PM
Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/07/2024
7:22 AM
Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
6:37 AM
Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
5:06 PM
BlackRock, Inc. (Filed by)
Tourmaline Bio, Inc. (Subject)
Tourmaline Bio (Subject)
Form SC 13G
10/10/2024
3:25 PM
Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2024
3:18 PM
Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
3:19 PM
Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2024
3:22 PM
Kulkarni Sandeep Chidambar (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
5:09 PM
Kulkarni Sandeep Chidambar (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
7:46 AM
Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
6:44 AM
Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
7:09 AM
Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
7:12 AM
Robinson Ryan F. (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
7:53 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Tourmaline Bio, Inc. (Subject)
Tourmaline Bio (Subject)
Form SC 13G
05/13/2024
6:15 AM
Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2024
6:09 AM
Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2024
6:45 AM
PFIZER INC (Filed by)
Tourmaline Bio, Inc. (Subject)
Tourmaline Bio (Subject)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:TRML) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners